Management of Renal Disease

  • Author: Mohamed G. Atta, MD, MPH (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 3/14/17 (What's New)

Summary

  • Equal and additive risk of morbidity and mortality that proteinuria signals is separate and distinct from risk identified by lesser eGFR (Figure 3)[KDIGO]
    • Underscores use of screening for and treating proteinuria regardless of GFR
  • After starting treatment, proteinuria level should be reassessed every 3 months until goal has been achieved

Action required